Researchers in Nottingham have launched a new study platform for the next generation of COVID-19 clinical research: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP).
The platform will bring together projects examining the impacts and lasting effects of COVID-19, translating findings from patients who are known to have contracted the virus into new approaches to treatment to support their recovery. To read about the background on all of the Nottingham Biomedical Research Centre’s COVID-19 research, click here.
Attend this webinar to find out about NoRCoRP plus:
– Background to COVID-19: clinical presentations, pathophysiology
– Existing treatment strategies
– Review of Nottingham portfolio of existing clinical trial and planned clinical studies in patients with COVID-19
– PHOSP-COVID and NoRCoRP: follow up studies of patients who have had COVID-19
– Opportunities for engagement with the NIHR Nottingham BRC for COVID related work
DURATION: 1.5 hours
This free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £190, but is delivered completely free of charge to participants.
Speaker Profile:
Professor Ian Hall, Director, NIHR Nottingham Biomedical Research Centre
Professor Ian is the Director of the NIHR Nottingham, Biomedical Research Centre. He is a chest physician based at NUH NHS Trust and the University of Nottingham, and has a long track record of research into the mechanisms underlying the development of a range of lung diseases. He currently chairs the national BRC Director’s forum, sits on NIHR Strategy Board, and is a member of UK-CTAP.
